Literature DB >> 10386649

Correlation between gamma-ray-induced G2 arrest and radioresistance in two human cancer cells.

T Tamamoto1, K Ohnishi, A Takahashi, X Wang, H Yosimura, H Ohishi, H Uchida, T Ohnishi.   

Abstract

PURPOSE: The correlation between radioresistance and gamma-ray-induced G2 arrest was examined in two human cancer cell lines, HeLa (cervical carcinoma) and MeWo (melanoma). METHODS AND MATERIALS: Cellular radioresistance was examined by a colony formation assay and Hoechst 33342 staining. G2 arrest induced by gamma-rays was examined by flow cytometry, and the accumulation of cyclin B1 and cdc2 proteins was analyzed using Western blotting.
RESULTS: HeLa was more resistant (10% survival dose[D10] = 10 Gy) than MeWo (D10 = 4 Gy) to gamma-rays. In HeLa, cell cycle analysis showed that G2 arrest was induced 10 or 24 h after irradiation of 10 or 4 Gy, respectively. In contrast, no clear G2 arrest in MeWo was observed after irradiation. Western blot analysis showed that cell cycle regulators, cyclin B1 and cdc2, were accumulated in HeLa but not in MeWo. The accumulation of cyclin B1 and cdc2 reached peak levels 24-34 h after irradiation of 10 Gy, and 24 h after irradiation of 4 Gy. In addition, Hoechst staining revealed similar increase in apoptotic bodies with time after irradiation in HeLa and MeWo at isosurvival doses.
CONCLUSION: Radioresistance of these human cancer cells is closely correlated with gamma-ray-induced G2 arrest, and cyclin B1 and cdc2 are possible regulators of G2 arrest.

Entities:  

Mesh:

Year:  1999        PMID: 10386649     DOI: 10.1016/s0360-3016(99)00072-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.

Authors:  Venkateswara Rao Gogineni; Arun Kumar Nalla; Reshu Gupta; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Cancer Lett       Date:  2011-09-06       Impact factor: 8.679

2.  Cell survival curve for primary hepatic carcinoma cells and relationship between SF(2) of hepatic carcinoma cells and radiosensitivity.

Authors:  Zhi-Zhong Liu; Wen-Ying Huang; Ju-Sheng Lin; Xiao-Sheng Li; Xiao Lan; Xiao-Kun Cai; Kuo-Huan Liang; Hai-Jun Zhou
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 3.  Mitogen-activated protein kinases and their role in radiation response.

Authors:  Anupama Munshi; Rajagopal Ramesh
Journal:  Genes Cancer       Date:  2013-09

4.  In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.

Authors:  Eun Joo Chung; Aaron P Brown; Hiroaki Asano; Mariana Mandler; William E Burgan; Donna Carter; Kevin Camphausen; Deborah Citrin
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

5.  Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.

Authors:  Congrong Yang; Yadi Wang; Fuli Zhang; Guogui Sun; Chenglin Li; Shaowu Jing; Qing Liu; Yunjie Cheng
Journal:  Mol Biol Rep       Date:  2013-08-13       Impact factor: 2.316

6.  Enhancement of viability of radiosensitive (PBMC) and resistant (MDA-MB-231) clones in low-dose-rate cobalt-60 radiation therapy.

Authors:  Patrícia Lima Falcão; Bárbara Miranda Motta; Fernanda Castro de Lima; Celso Vieira Lima; Tarcísio Passos Ribeiro Campos
Journal:  Radiol Bras       Date:  2015 May-Jun

Review 7.  Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.

Authors:  Abhishek A Solanki; Stanley L Liauw
Journal:  Open Access J Urol       Date:  2011-06-15

Review 8.  Radiation-induced signaling pathways that promote cancer cell survival (review).

Authors:  Ashley L Hein; Michel M Ouellette; Ying Yan
Journal:  Int J Oncol       Date:  2014-08-20       Impact factor: 5.650

Review 9.  Cell Signaling Pathways That Promote Radioresistance of Cancer Cells.

Authors:  Michel M Ouellette; Sumin Zhou; Ying Yan
Journal:  Diagnostics (Basel)       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.